NCT05961839
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05961839
Title Study of SGR-2921 in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Schrodinger, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
The University of Kansas Clinical Research Center Fairway Kansas 66205 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
The Ohio State University Wexner Medical Center - James Cancer Hospital Columbus Ohio 43210 United States Details
Oncology Associates of Oregon, P.C. Eugene Oregon 97401 United States Details
Oregon Health & Science University - Knight Cancer Institute - Center of Hematologic Malignancies Portland Oregon 97239 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization Philadelphia Pennsylvania 19107 United States Details
TriStar Bone Marrow Transplant, LLC Nashville Tennessee 37203 United States Details
St. David's South Austin Medical Center Austin Texas 78745 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field